Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors
Rajabali Daroudi; Mehrzad Mirzania; Nazila Nikravanfard; Sanambar Sadighi; Zahra Sedighi; Kazem Zendehdel
Author Information: Cancer Research Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.